Boz, C. Et Al. 2005. Neutralising antibodies reduce the effect of interferon on relapse rate: the British Columbia experience, Canada. 21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS , (Thessaloniki, Greece).

Boz, C., Gibbs, E., Grossberg, S., & Oger, J., (2005). Neutralising antibodies reduce the effect of interferon on relapse rate: the British Columbia experience, Canada . 21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS, Thessaloniki, Greece

Boz, CAVİT Et Al. "Neutralising antibodies reduce the effect of interferon on relapse rate: the British Columbia experience, Canada," 21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS, Thessaloniki, Greece, 2005

Boz, CAVİT Et Al. "Neutralising antibodies reduce the effect of interferon on relapse rate: the British Columbia experience, Canada." 21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS , Thessaloniki, Greece, 2005

Boz, C. Et Al. (2005) . "Neutralising antibodies reduce the effect of interferon on relapse rate: the British Columbia experience, Canada." 21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS , Thessaloniki, Greece.

@conferencepaper{conferencepaper, author={CAVİT BOZ Et Al. }, title={Neutralising antibodies reduce the effect of interferon on relapse rate: the British Columbia experience, Canada}, congress name={21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS}, city={Thessaloniki}, country={Greece}, year={2005}}